NCT05849597View on ClinicalTrials.gov

Dexmedetomidinine in the Prevention of Postoperative Delirium in the Intensive Care Unit After Cardiac Surgery

PHASE3RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

February 28, 2025

Study Completion Date

June 30, 2025

Conditions
Intensive Care Unit Delirium
Interventions
DRUG

Dexmedetomidine

Upon arrival to the intensive care unit after open heart surgery, the patients will be sedated with continuous dexmedetomidine infusion in doses 0.2-0.7 mcg/kg/h.

DRUG

Propofol

Upon arrival to the intensive care unit after open heart surgery, the patients will be sedated with continuous propofol infusion in doses 1-2 mg/kg/h.

Trial Locations (1)

21204

RECRUITING

Institute of Cardiovascular Diseases of Vojvodina, Kamenitz

All Listed Sponsors
lead

University of Novi Sad

OTHER